ZA919435B - Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans - Google Patents

Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans

Info

Publication number
ZA919435B
ZA919435B ZA919435A ZA919435A ZA919435B ZA 919435 B ZA919435 B ZA 919435B ZA 919435 A ZA919435 A ZA 919435A ZA 919435 A ZA919435 A ZA 919435A ZA 919435 B ZA919435 B ZA 919435B
Authority
ZA
South Africa
Prior art keywords
xanthines
humans
inhibiting
preparation
effects
Prior art date
Application number
ZA919435A
Other languages
English (en)
Inventor
James A Bianco
A Bianco James
Jack W Singer
W Singer Jack
William J Novick Jr
J Novick William Jr
Original Assignee
Hoechst Roussel Pharma
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Hutchinson Fred Cancer Res filed Critical Hoechst Roussel Pharma
Publication of ZA919435B publication Critical patent/ZA919435B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA919435A 1990-11-30 1991-11-29 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans ZA919435B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62047990A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
ZA919435B true ZA919435B (en) 1992-08-26

Family

ID=24486117

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919435A ZA919435B (en) 1990-11-30 1991-11-29 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans

Country Status (10)

Country Link
EP (1) EP0493682A3 (hu)
JP (1) JPH0525048A (hu)
KR (1) KR920009398A (hu)
AU (1) AU8824791A (hu)
CA (1) CA2056800A1 (hu)
HU (1) HUT59603A (hu)
IE (1) IE914162A1 (hu)
IL (1) IL100194A0 (hu)
PT (1) PT99650A (hu)
ZA (1) ZA919435B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109796C (en) * 1991-05-24 2004-04-27 James A. Bianco Modulation of cellular response to external stimuli
DE4430127A1 (de) * 1994-08-25 1996-03-14 Hoechst Ag Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat
DE4430128A1 (de) 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
US6323201B1 (en) 1994-12-29 2001-11-27 The Regents Of The University Of California Compounds for inhibition of ceramide-mediated signal transduction
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
KR20030007244A (ko) * 2002-10-04 2003-01-23 주식회사 코티티정보통신 온/오프 후크 스위치가 장착된 핸드셋을 가진 전화기
US20090239886A1 (en) * 2008-02-29 2009-09-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2011028835A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20130324564A1 (en) 2010-09-01 2013-12-05 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)-dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CN104364255A (zh) 2012-04-13 2015-02-18 康塞特医药品有限公司 取代的黄嘌呤衍生物
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063827B1 (fr) * 1980-05-02 1985-08-14 Societe Des Produits Nestle S.A. 1-Isopropyl- et 1-isobutyl-3,7-diméthylxanthine comme médicaments
IL100533A (en) * 1986-12-31 1994-05-30 Hoechst Roussel Pharma Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel

Also Published As

Publication number Publication date
CA2056800A1 (en) 1992-05-31
EP0493682A3 (en) 1992-11-19
IL100194A0 (en) 1992-08-18
IE914162A1 (en) 1992-06-03
EP0493682A2 (en) 1992-07-08
HU913722D0 (en) 1992-02-28
PT99650A (pt) 1992-11-30
HUT59603A (en) 1992-06-29
KR920009398A (ko) 1992-06-25
JPH0525048A (ja) 1993-02-02
AU8824791A (en) 1992-06-04

Similar Documents

Publication Publication Date Title
GB9204354D0 (en) Compounds for medicinal use
ZA923068B (en) Optimized tablet formulation
EP0493682A3 (en) Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
GB9118603D0 (en) Process for the preparation of alcohols
GB9004950D0 (en) Controlled release formulation
IL100195A0 (en) Use of xanthines for the preparation of a medicament having immuno suppressing activity
HRP931429B1 (en) Process for the preparation of amlodipin benzensulphonate
EP0501379A3 (en) Xanthine compounds
GB2222743B (en) Interferometry
EP0542106A3 (en) Process for the preparation of polyisocyanates
EP0523671A3 (en) Process for the preparation of chlorofluoronitrobenzenes
EP0480493A3 (en) Processes for the preparation of nitrogen-containing compounds
GB9302418D0 (en) Novel di-and polyamino compounds for use in the preparation of polyurethanes
HUT69309A (en) Process for the preparation of 2-alkoxymethyl-acrolein
EP0518013A3 (en) Process for the preparation of 1-alkoxy-2-dialkylaminoethanes
ZA93615B (en) Preparation of 2-amino-6-chloropurine
ZA925371B (en) Process for the preparation of 17-substituted-4-aza-5-androstan-3-one
ZA921040B (en) Process for the preparation of 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and similar compounds
EP0523619A3 (en) Process for the preparation of n-cyanimidocarbonates
EP0523668A3 (en) Process for the preparation of difluorobenzaldehydes
EP0537605A3 (en) Process for the preparation of 4-halogenebenzylic alcohols
GB9000241D0 (en) Pharmaceutical use
IL101304A0 (en) Process for the preparation of n-alkylsulfonamides
EP0548618A3 (en) Process for the preparation of 2-aminobenzaldehydes
EP0534249A3 (en) Process for the preparation of 3-phenyl-2-propenones